×
ADVERTISEMENT

irritable bowel syndrome

Gut-Directed Hypnotherapy App Improves IBS Symptoms

A gut-directed hypnotherapy program conducted via a downloadable app was shown to improve GI symptoms associated ...

FEBRUARY 20, 2023

Mortality Rates Higher in Opioid-Dependent IBD Patients

Hospitalized inflammatory bowel disease (IBD) patients with opioid dependence have a threefold risk for in-hospital ...

AUGUST 18, 2022

Rifaximin Improves Abdominal Pain for Irritable Bowel Syndrome With Diarrhea

Oral rifaximin was found highly efficacious in simultaneously controlling abdominal pain and bloating in patients ...

NOVEMBER 1, 2019

FDA Permits Marketing of First Device for IBS Pain in Pediatric, Adolescent Patients

The FDA is permitting marketing of the first medical device to aid in the reduction of functional abdominal pain in ...

JUNE 10, 2019

Value-Based Model for IBD Improves Outcomes, Lowers Costs

Transitioning from a fee-for-service model to value-based care can lead to massive improvements in patient outcomes ...

MAY 1, 2017

Pregabalin Controls Pain of Irritable Bowel Syndrome In Placebo-Controlled Trial

Las Vegas—Treatment with pregabalin, a GABAergic anticonvulsant licensed for use for neuropathic pain, ...

APRIL 28, 2017

FDA Warns IBS Drug Linked to Acute Abdominal Pain

The FDA reported that eluxadoline (Viberzi, Allergan) has been linked to severe pancreatitis and death in patients ...

APRIL 25, 2017

Placebo Plus Usual Treatment Achieves Clinically Significant Back Pain Relief

A placebo of a pill added to treatment as usual for chronic low back pain resulted in clinically significant ...

FEBRUARY 9, 2017

Load more